AstraZeneca to launch QTERN in India with DCGI marketing authorization approval
Posted on27 Sep 2019
Comments0
AstraZeneca Pharma has received import and market permission in Form 45 (marketing authorization) for QTERN (fixed dose combination of dapagliflozin 10mg +... Read More
Delhi HC scraps government ban on 344 fixed dose combination
The high court in Delhi quashed on Thursday a central government order banning 344 fixed dose combinations (FDCs) of drugs. The verdict... Read More
US FDA approves Aralez’s aspirin & omeprazole fixed dose combination
Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved once-daily Yosprala, the... Read More
USFDA nod for Allergan’s FDC Byvalson (nebivolol and valsartan) 5 mg/ 80 mg tablets for hypertension
Allergan plc got approval of Byvalson (nebivolol and valsartan) 5 mg/ 80 mg tablets, by the US Food and Drug Administration (FDA) for... Read More
Fixed Dose Combination Ban: Now NPPA sent back 200 fixed dose combination applications
Posted on23 Mar 2016
Comments0
India’s drug price regulator National Pharmaceutical Pricing Authority (NPPA) has sent back 200 applications from various pharmaceutical companies, asking them to review... Read More